Skip to content

13F-HR filed by Signpost Capital Advisors, LP

Signpost Capital Advisors, LP filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-13, with 9 holding rows worth $81,670,000.

Accession
0001560812-17-000001
Filed
2017-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 13 entries on the cover page, a total value of $81,670,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $81,670,000 with VALUE read as thousands by filing date, 13F file number 028-15208. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KRAFT HEINZ CO500754906COM277,000$24,188,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CALPINE CORP131347304COM1,541,173$17,615,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CALPINE CORP131347904COM765,000$8,744,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
TRIPADVISOR INC896945201COM183,300$8,500,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
DAVITA INC COM23918K108Stock114,776$7,368,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SERITAGE GROWTH PPTYS81752R100CL A167,500$7,154,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MEDICINES CO584688105COM110,883$3,763,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
RETROPHIN INC761299106COM163,741$3,100,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock33,065$1,238,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001560812-17-000001this filing2017-02-13acceptance time not in the bulk data set